137 related articles for article (PubMed ID: 19933408)
1. Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial.
Issa VS; Amaral AF; Cruz FD; Ferreira SM; Guimarães GV; Chizzola PR; Souza GE; Bacal F; Bocchi EA
Circ Heart Fail; 2010 Jan; 3(1):82-8. PubMed ID: 19933408
[TBL] [Abstract][Full Text] [Related]
2. Letter by Rassi et al regarding article, "Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial".
Rassi A; Rassi A
Circ Heart Fail; 2010 May; 3(3):e11; author reply e15. PubMed ID: 20484185
[No Abstract] [Full Text] [Related]
3. Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.
Bestetti RB; Otaviano AP; Cardinalli-Neto A; da Rocha BF; Theodoropoulos TA; Cordeiro JA
Int J Cardiol; 2011 Sep; 151(2):205-8. PubMed ID: 20591516
[TBL] [Abstract][Full Text] [Related]
4. Glycemia and prognosis of patients with chronic heart failure--subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial.
Issa VS; Amaral AF; Cruz FD; Ayub-Ferreira SM; Guimarães GV; Chizzola PR; Souza GE; Bocchi EA
Am Heart J; 2010 Jan; 159(1):90-7. PubMed ID: 20102872
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
[TBL] [Abstract][Full Text] [Related]
7. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
Koelling TM; Joseph S; Aaronson KD
J Heart Lung Transplant; 2004 Dec; 23(12):1414-22. PubMed ID: 15607672
[TBL] [Abstract][Full Text] [Related]
8. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
[TBL] [Abstract][Full Text] [Related]
9. Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial.
Ayub-Ferreira SM; Mangini S; Issa VS; Cruz FD; Bacal F; Guimarães GV; Chizzola PR; Conceição-Souza GE; Marcondes-Braga FG; Bocchi EA
PLoS Negl Trop Dis; 2013; 7(4):e2176. PubMed ID: 23638197
[TBL] [Abstract][Full Text] [Related]
10. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
Haas SJ; Vos T; Gilbert RE; Krum H
Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
[TBL] [Abstract][Full Text] [Related]
11. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
[TBL] [Abstract][Full Text] [Related]
12. Is Chagas cardiomyopathy an independent risk factor for patients with heart failure?
Braga JC; Reis F; Aras R; Dantas N; Bitencourt A; Neves FS; Latado AL
Int J Cardiol; 2008 May; 126(2):276-8. PubMed ID: 17467084
[TBL] [Abstract][Full Text] [Related]
13. Influence of global region on outcomes in heart failure β-blocker trials.
O'Connor CM; Fiuzat M; Swedberg K; Caron M; Koch B; Carson PE; Gattis-Stough W; Davis GW; Bristow MR
J Am Coll Cardiol; 2011 Aug; 58(9):915-22. PubMed ID: 21851879
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of heart failure with beta-blockers?].
Osterziel KJ; Dietz R
Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
[TBL] [Abstract][Full Text] [Related]
15. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers.
Bobbio M; Ferrua S; Opasich C; Porcu M; Lucci D; Scherillo M; Tavazzi L; Maggioni AP;
J Card Fail; 2003 Jun; 9(3):192-202. PubMed ID: 12815569
[TBL] [Abstract][Full Text] [Related]
16. [The use of beta blockers in heart failure: clinical studies].
Cobelli F
Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
[TBL] [Abstract][Full Text] [Related]
17. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
18. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
Ritt LE; Carvalho AC; Feitosa GS; Pinho-Filho JA; Macedo CR; Vilas-Boas F; Andrade MV; Feitosa-Filho GS; Almeida AJ; Barojas M; Lopes RD
Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):538-43. PubMed ID: 22513344
[TBL] [Abstract][Full Text] [Related]
19. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers.
O'Neill JO; Young JB; Pothier CE; Lauer MS
Circulation; 2005 May; 111(18):2313-8. PubMed ID: 15867168
[TBL] [Abstract][Full Text] [Related]
20. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
Anker SD; Clark AL; Winkler R; Zugck C; Cicoira M; Ponikowski P; Davos CH; Banasiak W; Zardini P; Haass M; Senges J; Coats AJ; Poole-Wilson PA; Pitt B
Int J Cardiol; 2006 Sep; 112(2):234-42. PubMed ID: 16846656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
